Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2025-12-24 @ 11:57 PM
NCT ID:
NCT06564051
Eligibility Criteria:
Inclusion Criteria:
* Individuals with chronic hepatitis C who are to begin therapy with DAA
* Willing to submit a peripheral blood sample at baseline, end of therapy, 12 weeks after the end of therapy, and 52 weeks from baseline
Exclusion Criteria:
* Individuals with chronic hepatitis C who have cirrhosis
* Individuals with chronic hepatitis C who have a past history of a lymphoproliferative disorder AND for which they received chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06564051
Study Brief:
Protocol Section:
NCT06564051